SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-22-005988
Filing Date
2022-04-26
Accepted
2022-04-26 16:41:43
Documents
11
Period of Report
2022-06-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A imgn-20220615xdef14a.htm DEF 14A 1388700
2 GRAPHIC imgn-20220615xdef14a004.jpg GRAPHIC 6096
3 GRAPHIC imgn-20220615xdef14a001.jpg GRAPHIC 3938
4 GRAPHIC imgn-20220615xdef14a025.jpg GRAPHIC 132650
5 GRAPHIC imgn-20220615xdef14a026.jpg GRAPHIC 120547
6 GRAPHIC imgn-20220615xdef14a017.jpg GRAPHIC 43144
7 GRAPHIC imgn-20220615xdef14a003.jpg GRAPHIC 6785
8 GRAPHIC imgn-20220615xdef14a005.jpg GRAPHIC 5387
9 GRAPHIC imgn-20220615xdef14a002.jpg GRAPHIC 6192
10 GRAPHIC imgn-20220615xdef14a018.jpg GRAPHIC 22926
11 GRAPHIC imgn-20220615xdef14a016.jpg GRAPHIC 29658
  Complete submission text file 0001558370-22-005988.txt   1911012
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-17999 | Film No.: 22854944
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences